International Journal of
Reproductive Biomedicine
Sun, Oct 13, 2024
[Archive]
Volume 20, Issue 9 (September 2022)
IJRM 2022, 20(9): 753-760 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Baybordi E, Mohseni J, Mosapour P. The effect of platelet-rich plasma on the improvement of pregnancy results in repeated implantation failure: A randomized controlled trial. IJRM 2022; 20 (9) :753-760
URL: http://ijrm.ir/article-1-1990-en.html
URL: http://ijrm.ir/article-1-1990-en.html
1- ACECR Infertility Treatment Center, Tabriz, Iran. , baybordi@acecr.ac.ir
2- ACECR Infertility Treatment Center, Tabriz, Iran.
2- ACECR Infertility Treatment Center, Tabriz, Iran.
Abstract: (935 Views)
Background: The success rate of infertility treatment depends on many different factors.
Objective: This study aimed to determine the effect of platelet-rich plasma (PRP) on the improvement of pregnancy outcomes in participants with repeated implantation failure.
Materials and Methods: The study is a randomized triple-blind clinical trial. The study population was 118 women with repeated implantation failure during assisted reproductive technology treatment at Tabriz Jihad-e Daneshgahi ART Center from May 2017 to December 2019. Intervention: Intrauterine injection of autologous PRP. Standard treatment of fetal transfer to the uterine cavity was performed without intrauterine PRP injection in the control group: After 4 wk, the level of β-human chorionic gonadotropin hormone in participants' blood was measured.
Results: Comparing the effect of intrauterine injection of PRP in 2 groups showed the level of β-human chorionic gonadotropin positive in the intervention group was 21 (43.8%), in the control group was 12 (26.1%), odds ratio = 2.20 (0.92-5.26) and p = 0.073.
Conclusion: The therapeutic effect in the intervention group compared to the control regarding the outcome of a successful pregnancy showed that intrauterine injection of PRP can be effective in improving pregnancy outcomes, although this improvement is not significant.
Objective: This study aimed to determine the effect of platelet-rich plasma (PRP) on the improvement of pregnancy outcomes in participants with repeated implantation failure.
Materials and Methods: The study is a randomized triple-blind clinical trial. The study population was 118 women with repeated implantation failure during assisted reproductive technology treatment at Tabriz Jihad-e Daneshgahi ART Center from May 2017 to December 2019. Intervention: Intrauterine injection of autologous PRP. Standard treatment of fetal transfer to the uterine cavity was performed without intrauterine PRP injection in the control group: After 4 wk, the level of β-human chorionic gonadotropin hormone in participants' blood was measured.
Results: Comparing the effect of intrauterine injection of PRP in 2 groups showed the level of β-human chorionic gonadotropin positive in the intervention group was 21 (43.8%), in the control group was 12 (26.1%), odds ratio = 2.20 (0.92-5.26) and p = 0.073.
Conclusion: The therapeutic effect in the intervention group compared to the control regarding the outcome of a successful pregnancy showed that intrauterine injection of PRP can be effective in improving pregnancy outcomes, although this improvement is not significant.
Type of Study: Original Article |
Subject:
Assisted Reproductive Technologies
References
1. Timeva T, Shterev A, Kyurkchiev S. Recurrent implantation failure: he role of the endometrium. J Reprod Infertil 2014; 15: 173-183.
2. Nazari L, Salehpour S, Hoseini S, Zadehmodarres S, Ajori L. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod BioMed 2016; 14: 625-628. [DOI:10.29252/ijrm.14.10.625] [PMID] [PMCID]
3. Choi Y, Kim HR, Lim EJ, Park M, Yoon JA, Kim YS. Integrative analyses of uterine transcriptome and microRNAome reveal compromised LIF-STAT3 signaling and progesterone response in the endometrium of patients with recurrent/repeated implantation failure (RIF). PloS One 2016; 11: e0157696. [DOI:10.1371/journal.pone.0157696] [PMID] [PMCID]
4. Katzorke N, Vilella F, Ruiz M, Krüssel JS, Simon C. Diagnosis of endometrial-factor infertility: Current approaches and new avenues for research. Geburtshilfe Frauenheilkunde 2016; 76: 699-703. [DOI:10.1055/s-0042-103752] [PMID] [PMCID]
5. Cavalcante MB, Costa FD, Barini R, Júnior EA. Granulocyte colony-stimulating factor and reproductive medicine: A review. Iran J Reprod Med 2015; 13: 195-202.
6. Dhillon RS, Schwarz EM, Maloney MD. Platelet-rich plasma therapy-future or trend? Arthritis Res Ther 2012; 14: 219. [DOI:10.1186/ar3914] [PMID] [PMCID]
7. Farimani M, Bahmanzadeh M, Poorolajal J. A new approach using autologous platelet-rich plasma (PRP) to treat infertility and to improve population replacement rate. J Res Health Sci 2016; 16: 172-173.
8. Mehrafza M, Kabodmehri R, Nikpouri Z, Pourseify G, Raoufi A, Eftekhari A, et al. Comparing the impact of autologous platelet-rich plasma and granulocyte colony stimulating factor on pregnancy outcome in patients with repeated implantation failure. J Reprod Infertil 2019; 20: 35-41.
9. Coksuer H, Akdemir Y, Ulas Barut M. Improved in vitro fertilization success and pregnancy outcome with autologous platelet-rich plasma treatment in unexplained infertility patients that had repeated implantation failure history. Gynecol Endocrinol 2019; 35: 815-818. [DOI:10.1080/09513590.2019.1597344] [PMID]
10. Maleki-Hagiagha A, Razavi M, Rouholamin S, Rezaeinejad M, Maroufizadeh S, Sepidarkish M. Intrauterine infusion of autologous platelet rich plasma in women undergoing assisted reproduction: A systematic review and meta-analysis. J Reprod Immunol 2020; 137: 103078. [DOI:10.1016/j.jri.2019.103078] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
